ENB Therapeutics, Inc
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| ENB003 Plus Pembrolizumab Phase 1b/2a in Solid Tumors (NCT04205227) | ENB Therapeutics, Inc | 2020-02-18 |
Track ENB Therapeutics, Inc automatically
Every clearance here is in the API, with alerts when new ones post.